Asia Pacific Radiodermatitis Market Size & Outlook

The radiodermatitis market in Asia Pacific is expected to reach a projected revenue of US$ 146.3 million by 2030. A compound annual growth rate of 4.6% is expected of Asia Pacific radiodermatitis market from 2025 to 2030.
Revenue, 2024 (US$M)
$112.1
Forecast, 2030 (US$M)
$146.3
CAGR, 2025 - 2030
4.6%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific radiodermatitis market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific radiodermatitis market highlights

  • The Asia Pacific radiodermatitis market generated a revenue of USD 112.1 million in 2024.
  • The market is expected to grow at a CAGR of 4.5% from 2025 to 2030.
  • In terms of segment, topical was the largest revenue generating product in 2024.
  • Topical is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.


Asia Pacific data book summary

Market revenue in 2024USD 112.1 million
Market revenue in 2030USD 146.3 million
Growth rate4.5% (CAGR from 2025 to 2030)
Largest segmentTopical
Fastest growing segmentTopical
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTopical, Dressings
Key market players worldwideSmith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 25.4% of the global radiodermatitis market in 2024.
  • Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 146.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiodermatitis Market Companies

Name Profile # Employees HQ Website
BMG Pharma View profile 11-50 Milan, Lombardia, Italy, Europe https://www.bmgpharma.com
Stratpharma View profile 101-250 Basel, Basel-Stadt, Switzerland, Europe http://stratpharma.com/
Alliqua BioMedical View profile 11-50 Yardley, Pennsylvania, United States, North America http://alliqua.com/
Molnlycke Health Care View profile 5001-10000 Gothenburg, Vastra Gotaland, Sweden, Europe http://www.molnlycke.com/
Integra LifeSciences View profile 5001-10000 Princeton, New Jersey, United States, North America http://www.integralife.com
ConvaTec Group PLC View profile 10136 20 Eastbourne Terrace, 7th Floor, Paddington, London, United Kingdom, W2 6LG https://www.convatecgroup.com
Smith & Nephew PLC View profile 18452 Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE https://www.smith-nephew.com
3M Co View profile 85000 3M Center, St. Paul, MN, United States, 55144 https://www.3m.com

Asia Pacific radiodermatitis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.


Topical was the largest segment with a revenue share of 71.28% in 2024. Horizon Databook has segmented the Asia Pacific radiodermatitis market based on topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific held the largest market share and is the fastest growing market in terms of revenue generation from radiodermatitis market growth.

Presence of supportive government initiatives such as Asia Pacific Radiation burn Congress (APBC) and high-untapped opportunities are the important factors anticipating the growth of Asia Pacific regional market over the forecast period.

In addition, continuous R&D activities by the key market players for better innovative products are expected to fuel market growth over the forecast period. India, Japan, and China are the major contributors to radiodermatitis market growth in Asia Pacific region.

Reasons to subscribe to Asia Pacific radiodermatitis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific radiodermatitis market databook

  • Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific radiodermatitis market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific radiodermatitis market size, by country, 2018-2030 (US$M)

Asia Pacific Radiodermatitis Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific radiodermatitis market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online